Cyclacel Pharmaceuticals Inc CYCC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/16/22 EDT
1.35quote price arrow up+1.35 (UNCH)
Volume
565
Close
1.42quote price arrow up+0.03 (+2.16%)
Volume
154,594
52 week range
1.29 - 7.95
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High7.95
  • 52 Week High Date05/21/21
  • 52 Week Low1.29
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap14.19M
  • Shares Out9.99M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-63.5

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High7.95
  • 52 Week High Date05/21/21
  • 52 Week Low1.29
  • 52 Week Low Date05/12/22
  • Market Cap14.19M
  • Shares Out9.99M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-63.5

RATIOS/PROFITABILITY

  • EPS (TTM)-2.06
  • P/E (TTM)-0.69
  • Fwd P/E (NTM)-0.59
  • EBITDA (TTM)-22.894M
  • ROE (TTM)-54.13%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,029.33%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cyclacel Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The Company is focused on the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival. The Company's pipeline...
Christopher Henney Ph.D.
Independent Chairman of the Board
Spiro Rombotis
President, Chief Executive Officer, Director
Paul Mcbarron
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Secretary, Director
Address
200 Connell Dr Ste 1500
Berkeley Heights, NJ
07922-2811
United States

Top Peers

SYMBOLLASTCHG%CHG
ARTL
Artelo Biosciences Inc
0.3216-0.0089-2.6929%
NRBO
Neurobo Pharmaceuticals Inc
0.5401+0.0309+6.07%
TENX
Tenax Therapeutics Inc
0.5712+0.0035+0.62%
MITO
Stealth BioTherapeutics Corp
0.2432+0.0174+7.71%
NNVC
NanoViricides Inc
1.45+0.16+12.19%